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A B S T R A C T
Malignant transformation is characterized by a phenotype “switch” from E- to N-cadherin – a major hallmark of
epithelial to mesenchymal transition (EMT). The increased expression of N-cadherin is commonly followed by a
growing capacity for migration as well as resistance to apoptosis. Integrin Linked Kinase (ILK) is a key molecule
involved in EMT and progression of cancer cells. ILK is known as a major signaling mediator involved in cad-
herin switch, but the specific mechanism through which ILK modulates N-cadherin expression is still not clear.
Studies were carried out on human melanoma WM793 and 1205Lu cell lines. Expression of proteins was
analyzed using PCR and Western Blot; siRNA transfection was done for ILK. Analysis of cell signaling pathways
was monitored with phospho-specific antibodies. Subcellular localization of protein was studied using the
ProteoExtract Subcellular Kit and Western blot analysis.
Our data show that ILK knockdown by siRNA did suppress N-cadherin expression in melanoma, but only at
the protein level. The ILK silencing-induced decrease of N-cadherin membranous expression in melanoma
highlights the likely crucial role of ILK in the coordination of membrane trafficking through alteration of Rab
expression. It is essential to understand the molecular mechanism of increased N-cadherin expression in cancer
to possibly use it in the search of new therapeutic targets.
1. Introduction
A reduction or loss in the expression of E-cadherin and induction of
N-cadherin expression has been recognized as an important primary
event in melanoma progression [1]. The process, also known as the
cadherin switch, is a hallmark of the Epithelial Mesenchymal Transition
(EMT) process, which is probably required for epithelial cells to adopt
mesenchymal characteristics [2]. In spite of the fact, that melanoma
develops from cells of neural crest cells - melanocytes – the hallmarks of
EMT play an essential role in progression of melanoma. EMT is a phe-
nomenon associated with downregulation of E-cadherin and upregula-
tion of N-cadherin what contribute to the metastatic potential of mel-
anocytes during early step in melanoma development. N-cadherin is
involved in the process allowing for dissemination of melanoma cells
from the original tissue to distant organs; the expression of N-cadherin
is responsible for increased proliferation and invasion of melanoma
cells [3,4]. We have previously showed that in melanoma cells, EMT
markers are dependent on ILK activity [5]. ILK is commonly acknowl-
edged as one of the important cellular signaling kinases [6]. Interacting
with other elements of downstream signaling pathways, ILK regulates
cell proliferation, cell-extracellular matrix interaction, apoptosis or cell
migration. The role of ILK in the control of N-cadherin expression in
melanoma is not well understood. We showed that silencing of ILK in
melanoma cells resulted in the decrease of an important EMT marker –
N-cadherin expression on the protein level. EMT transition involves
genetic and epigenetic changes as well as an alteration in protein
transcription, translation, and post-translational modification, and –
unexpectedly – alteration in membrane trafficking [7]. A wealth of
evidence points to endocytosis and recycling as important factors in the
regulation of membranous expression of N-cadherin [8–10]. En-
docytosis regulates a variety of cellular functions including proteins
internalization from the surface, recycling of integrins, receptor and
adhesion molecules, as well as protein degradation. The receptor
clearance defines the specificity with which a cell can react to extra-
cellular stimuli. This shows that endocytosis may govern many cellular
signaling processes, as well as EMT. Though endocytosis and cellular
signaling have earlier been described as distinct processes, endocytosis
is currently seen as a phenomenon associated with many aspects of
cellular signaling [11,12]. Ras-associated binding (Rab)-GTPases are
members of the Ras family of small GTPases and they are responsible
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for regulation of the expression of surface receptors [13–15]. Rab
proteins (5, 4, 11 and 7), which are engaged in endocytosis, recycling,
and lysosomal degradation, play an essential role in the regulation of
membranous expression of N-cadherin [16,17]. Endosomal motility
depends also on the interaction with microtubules and actin cytoske-
leton. An important scaffold protein that modulates both actin and
microtubule dynamics is ILK [18]. We previously showed that ILK can
regulate the N-cadherin expression through an unknown mechanism
only on the protein level in melanoma [5], and can also instigate cad-
herin switch of bladder cancer through transcriptional regulation by
Twsit-1, Zeb-1, Snail and PARP-1 [19].
This article presents the results of our recent study on the me-
chanism of the ILK silencing -induced decrease of N-cadherin mem-
branous expression in melanoma, highlighting the possibly crucial role
of ILK in the coordination of endocytosis by regulation of Rab expres-
sion.
2. Materials and methods
2.1. Cell culture
Human melanoma cell lines: WM793 (vertical growth phase – VGP)
and 1205Lu (metastatic) cell line was derived from lung metastases of
WM793 after subcutaneous injection into immunodeficient mice
[20,21]. 1205Lu cells are highly invasive and exhibit spontaneous
metastasis to lung and liver. Cell lines are used in the search for un-
derstanding the molecular mechanism of cancer signaling despite the
fact that cultured cells show instability of their metastatic phenotype
during loss of in vivo microenvironment. Spontaneous transformation
towards a more malignant phenotype may occur in RGP primary mel-
anoma cells but cells selected in animal models (like 1205Lu) have a
relatively stable metastatic phenotype. The comparison of melanoma
cell lines to melanoma tumors by Vincent and Postovita showed that
melanoma cell lines correspond transcriptionally to their respective
tumors. The majority of genes have a similar expression in cell lines and
tumors, but the biggest differences were observed in respect to immune
genes [22]. Cells were cultured in RPMI-1640 medium supplemented
with 10% fetal bovine serum and penicillin/streptomycin. Cells were
obtained from the ESTDAB Melanoma Cell Bank (Tubingen, Germa-
ny).Chloroquine was purchased from Sigma and was used in final
concentration 50 μM. Human endothelial aortic cells (HEAC) obtained
from Małgorzata Lasota (UJ CM, Faculty of Medicine, Department of
Transplantation, Poland) were cultured in endothelial medium EBM-2
(CC-3156; Lonza). For siRNA transfection and endothelial adhesion or
transendothelial migration assays serum-free medium Opti-MEM
(Gibco) was used. All cell lines are examined for mycoplasma infection
by PCR method.
2.2. siRNA transfection
Melanoma cells were grown until 60% confluency was reached and
then transfected using INTERFERin™ as per the manufacturer's protocol
(Polyplus Transfection) with three different 21 bp double-stranded
siRNA molecules specifically targeting the ILK (Ambion ID#288570;
ID#145116; ID#145117) or a control nonsilencing sequence (Ambion
ID#4611). WM793 cells were in each case transfected with 60 nM and
1205Lu cells with 80 nM siRNA, respectively. As transfection control,
melanoma cells were transfected 19 bp scrambled sequence with 3’dT
overhangs. The sequences have no significant homology to any known
human gene sequences. Since there were no differences between un-
transfected cells and silencer negative control cells (not shown), the
latter were selected as control cells in other experiments. After 24 h, the
medium was replaced with a fresh one and cells were grown for an
additional 24 h period (48 h post-transfection) prior to analysis.
2.3. Preparation of cytoplasmic, membrane, nuclear and cytoskeletal cell
lysates
Cytoplasmic, membrane, nuclear, and cytoskeletal extracts were
prepared using the ProteoExtract® Subcellular Proteome Extraction Kit
(MERC Millipore) as per the producer's protocol for frozen cell pellet in
amount 106 cells and afterwards equal amounts of protein were used for
immunoblot analysis.
2.4. Western blot analysis
Cells were lysed in sample buffer (0.0625 M Tris/HCl pH 6.8, 2%
SDS, 10% glycerol, 5% β-mercapto-ethanol). Cell lysates containing
equal amounts of protein were separated on 10% SDS-PAGE gels, and
subsequently transferred onto a PVDF membrane. Antibodies against:
ILK #611803, AKT #610861, GSK-3β #610201, phospho-GSK-
3β(Y216)#612,312, vimentin #550513 (all Transduction Laboratories,
BD), phospho-AKT(S473) #9271, phospho-GSK-3β(S9) #9336, Src
#2109, phosphor-Src (Y416) #6943, phosphor-p44/42 (Erk1/2)
(T202/Y204) #4370, Rab4 #2167, Rab5 #3547, Rab9 #5118, Rab11
#5589, Rab11FIP1#12849 (all Cell Signaling Technology), N-cadherin
#BTA7 (R&D) and β-actin #A1978, ZEB1#SAB35005144 (Sigma),
SNAIL #AP2054a (ABGENT), Calnexin #208883, HSP-90 #CA1023 (all
Calbiochem) were used to detect indicated proteins in dilution 1:1000.
The presence of the primary antibody was revealed with horseradish
peroxidase-conjugated secondary antibodies diluted 1:2000 (Cell
Signaling Technology Inc) and visualized with an enhanced chemilu-
minescence detection system (Bio-Rad), as previously described. β-actin
served as a loading control. All immunoblots were stripped with
stripping buffer containing 25 mM glycine-HCl, pH 2, 1% (wt / v) SDS
for 30 min, and incubated in antibody against β-actin (Sigma), which
served as a loading control. Molecular masses were estimated by re-
ference to standard proteins (Fermentas). To obtain quantitative results,
immunoblots were scanned using the public domain ImageJ software
(National Institute of Health). Each data point was normalized against
its corresponding β-actin data point.
2.5. RNA extraction, cDNA synthesis and RT-PCR analysis
RNA extraction was prepared using the RNAqueuus-Micro (Ambion)
as per the producer's protocol; afterwards, preparation of cDNA was
prepared using NGdART RT kit as per the manufacturer's protocol
(EURx). RT-PCR reaction was carried out with Color OpyiTaq PCR
Master Mix (EURx). The temperature profile of RT-PCR amplification
consisted of activation of Taq polymerase at 95 °C for 4 min, dena-
turation of cDNA at 95 °C for 30–45 s, applying primer annealing
temperature for 30–40 s, elongation at 72 °C for 40–60 s for the fol-
lowing 30 cycles and completion of the process by the extension step for
10 min. The following specific primers were used:
GAPDH; (59 °C, 30 s):
5′CACCGCCTCGGCTTGTCACAT 3′ and 5’CTGCTGTCTTGGGTGCA
TTGC3′;
N-CADHERIN; (60 °C, 40 s):
5′GTGCCATTAGCCAAGGGAATTCAGC3′ and.
5′CGAGGATACTCACCTTGTCCTTGCG 3′;
E-CADHERIN; (60 °C, 40 s):
5′GCCAAGCAGCAGTACATTCTACACG3′ and.
5′GTCGTTCTTCACGTGCTCAAAATCC3′;
The PCR reaction products were separated electrophoretically on
2% agarose gel and visualized with ethidium bromide.
2.6. Endothelial adhesion assay
For in vitro endothelial adhesion assay HEAC cells (1,5 × 105)
passages (3–5) were seeded in black-walled 24–well plates for 48 h
before adhesion assay. Melanoma cells dissociated with 0,02% EDTA
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solution (1 × 105) labeling with 5 μM Calcein AM (BD Pharmingen
cat.No 564061) for 30 min at 37 °C, after washing, were added to HEAC
monolayer for 0,5 h at 37 °C. After incubation, nonadherent melanoma
cells were removed from monolayer of HEAC and after washing with
PBS samples were measured on a plate reader (BIO-TEK). Quantitative
analysis of adherent cells was carried out by measuring the fluorescence
of samples at excitation/emission wavelengths of 495/515 nm sensi-
tivity 50.
2.7. Transendothelial migration assay
The in vitro transendothelial migration assay were study using
Millipore QCM Tumor Cell Transendothelial Cell migration Assay
(MERC Millipore cat.No. ECM558) according to producer's protocol.
The assay allows quantitative analysis of tumor cell migration. HEAC
cell passages (3–5) were used, 0,02% EDTA solution (Sigma) was used
as harvesting buffer for cancer cells detachment. After 20 h migrated
cells were stained and measured by OD 570 nm accordingly to the assay
instruction. Results were described as the value of tumor transen-
dothelial migration minus the amount of negative control chambers
contained HEACs only. The cells which migrated towards the opposite
side of the membrane were viewed under invert microscope, the images
of the migrated cells were taken using digital camera (Nikon, Tokyo,
Japan) as additional data.
2.8. Statistical analysis
Shapiro–Wilk W-test was used to check the normality of each
variable. Levene's test was used for assessed homogeneity of variance.
Statistical analyses of data from in vitro studies were performed by one-
way analysis of variance (ANOVA), followed by Dunnett's post hoc
comparison test to determine which values differed significantly from
the controls. All analyses were made using Statistica 13 software
(StatSoft Inc., Tulsa, OK, USA). Data were presented as mean ± SD and
considered statistically significant at *p < .05, **p < .01, and
***p < .001.
3. Results
3.1. siRNA-mediated knockdown of ILK results in the decrease of
prosurvival signaling
The expression and activity of ILK were also elevated in melanoma,
especially in cells sourced from advanced stages [23]. We received
comparable results; a higher level of ILK was observed in the metastatic
melanoma cell line compared with the one derived from VGP site [5].
Knockdown of ILK expression caused a significant reduction of Akt
activation with a negligible difference in its total expression. We used
phospho-specific antibodies against phospho-Akt (S473) for monitoring
expression of activated AKT. siRNA silencing of ILK resulted in the
activation of GSK-3β seeing as the phosphorylation on Ser 9 was
markedly lower, while the phosphorylation of GSK-3β on Tyr 216 was
higher in comparison to control melanoma cells (Fig. 1).We noticed
slight difference in the expression of total GSK-3β. Signaling molecules
activated by ILK also include Src family and Erk kinase. We observed a
visible decrease of activity of tested kinase Src, especially in WM793
cell line upon ILK silencing in comparison to control melanoma cells
(Fig. 1), but we did not notice changes in activation of ERK1/2 kinase.
siRNA for ILK effectively reduced the pro-survival pathway in mela-
noma cells.
3.2. ILK regulates N-cadherin protein levels
Loss of E-cadherin expression and induction of N-cadherin expres-
sion are hallmarks of the EMT process, and ILK signaling is known to
induce EMT. The studied melanoma cell lines – WM793 from VGP, and
1205Lu from metastasis – both express N-cadherin but no E-cadherin on
mRNA and protein levels (Fig. 2). In our previous work, we showed that
ILK knockdown was sufficient to down-regulate the expression of N-
cadherin protein as EMT marker in both cell lines [5]. In this study,
despite the decreased N-cadherin protein expression upon ILK silencing,
no difference on mRNA level was observed. However, melanoma cells
showed significantly decreased expression of EMT-inducing transcrip-
tional factors Zeb and Snail. Also, loss of nuclear translocation of Snail
was visible in WM 793 cell line (Fig. 3). ILK silencing was insufficient to
re-express E-cadherin on protein or mRNA level. These results suggest
that ILK in studied melanoma cells does not affect the transcription of
cadherins.
3.3. Silencing of ILK affects N-cadherin plasma membrane (surface)
expression
N-cadherin favors cell migration and invasion in many types of
cancers; hence, N-cadherin surface expression in cancer is an important
factor in cancer progression. In previous works, we showed that N-
cadherin expression contributes to increased proliferation and invasive
potential of studied melanoma cells [3,4]. We studied whether the ILK
signaling pathway is necessary for the reduction of N-cadherin protein
level, and also if it may influence endosomal recycling of N-cadherin to
the membrane surfaces. We checked intracellular localization of N-
cadherin after silencing of ILK in comparison to control non-silencing
RNA-treated melanoma cells. Western blot analysis of the subcellular
fraction showed that in melanoma cells N-cadherin is located in the
cytoplasm and membrane fraction, but after silencing of ILK, N-cad-
herin was reduced in the cytoplasm fraction and completely abolished
in the membrane fraction (Fig. 3). These results suggest that ILK sig-
naling is involved in directing N-cadherin to the cell surface.
3.4. ILK knockdown is sufficient for N-cadherin endocytosis
Endocytosis is a mechanism well known to terminate receptor sig-
naling, and required for the initiation of some signaling cascades [12].
Rab5 small G proteins function in endocytic processes at the plasma
membrane and are engaged in N-cadherin endocytosis. The siRNA re-
duction of ILK expression had significant effect on Rab5 protein levels
in both melanoma cell lines (Fig. 4). Rab5 expression was up-regulated
2.3-fold in WM793 and 1.7-fold in 1205Lu in comparison to control
cells. Our observations show that ILK can regulate N-cadherin en-
docytosis. Rab5 is vital for the early endocytic pathway but Rab7 reg-
ulates late endosomal transport, and Rab9 controls transport from the
late endosomes to trans-Golgi. Rab7 is involved in the degradation of
cadherins in epithelia and neurons because it is associated with early
sorting endosomes to a degradative compartment and is engaged in
autophagosome maturation. Rab9 is required in non-canonical autop-
hagy. We observed a stable level of Rab7 and an elevated level of Rab9
(1.5–fold in WM793 and 1.85 in 1205Lu) when ILK was knocked-down.
Taken together, these results demonstrate that ILK plays an im-
portant role in the regulation of the endocytic pathway.
3.5. ILK contribute to the recycling of N-cadherin to the cell surface
Two distinct pathways are described for membrane receptors' in-
ternalization to early endosomes and recycling to the plasma mem-
brane. Rab4 regulates delivery of early endosoms to the membrane in
the short-range recycling pathway, but Rab11 controls membrane
trafficking through long-range pathway. Both proteins are essential for
regular N-cadherin supply to the plasma membrane [9]. We detected a
significant decrease of expression of both Rab4 and Rab11 proteins, as
well as Rab11 interacting protein (Rab11FIP1) after silencing of ILK,
which is associated with inhibition of recycling of N-cadherin to the cell
surface (Fig. 4). We used chloroquine to study the effect of inhibition of
endosomes recycling to the plasma membrane on N-cadherin
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expression. Chloroquine and primaquine effectively inhibit recycling of
endocytosed integral membrane proteins such as TfR (Transferrin re-
ceptor) so they may be used as potent inhibitors for membrane trans-
port from endosomes to the plasma membrane [24]. As shown in Fig. 5,
the inhibition by chloroquine was sufficient to downregulate the ex-
pression of N-cadherin on protein level in both cell lines.
3.6. Reduction of N-cadherin expression by ILK pathway inhibit invasive
potential of melanoma cells
Cancer metastasis is a multistep process. The adhesion to the en-
dothelium and the penetration of circulating cancer cells into the en-
dothelium is a crucial step for cancer metastasis which involve N-cad-
herin. We checked whether the observed decreased of surface
expression of N-cadherin after silencing of ILK was sufficient to down
Fig. 1. The inhibitory effect of ILK knock-down on the activities of downstream pro-survival signaling. Melanoma cells were transfected with non-silencing control
siRNA or three different 21 bp double-stranded siRNA targeting the ILK. Protein expression was studied by Western blot 48 h after transfection. “+” refers to siRNA
ILK; “-“refers to control cells, as described in Materials and Methods. The histograms are a quantitative representation of data after densitometry (mean ± SD) of
three independent experiments. Β-actin was used as a protein loading control. Asterisks indicate significant differences from control cells. Values are denoted as
*p < .05, **p < .01, and ***p < .001.
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regulate metastatic potential. The invasive potential of melanoma cells
were studied as endothelial adhesion and transendothelial migration
assays. Attachment of melanoma cells on the endothelial monolayer
was significantly decrease after ILK knockdown in both cell lines
(Fig. 6). Also reduction of surface N-cadherin expression decreased the
amount of cells which were able to migrate across endothelial cells
monolayer (Fig. 7). Transendothelial migration was inhibited by si-
lencing of ILK in both WM793 and 1205Lu cells as a direct consequence
of downregulation of N-cadherin. The data support an important role of
ILK in regulation of N-cadherin surface exposition in melanoma cells.
4. Discussion
Evidence indicates that endocytosis controls cell adhesion and
thereby cell migration, growth, survival, and development [11,12].
Endocytosis is also harnessed by the EMT process to promote dynamic
changes in cellular identity to increase cancer progression. The key
regulators of vesicular membrane transport on both the endocytosis and
exocytosis are Rab proteins. Alteration in Rab protein expression has
been revealed in several human diseases and in a variety of cancers
[17,25]. Therefore, the precise molecular detail of the upstream
regulation of Rab proteins is an important point requiring clarification.
Our study underscores ILK as a critically important regulator of en-
dosomal recycling of N-cadherin in melanoma cells. Caswell and col-
leagues have previously suggested that integrins can regulate the ex-
pression of other receptors by regulating endocytosis [26]. We found
that ILK modulates the expression of Rab proteins associated with N-
cadherin endocytosis, degradation, or recycling. We observed a very
significant increase in Rab5 protein level after knockdown of ILK in the
studied melanoma cells, which may explain the observed decrease in
membrane expression of N-cadherin. Rab5 is important for sequestering
receptors and formation of early endosomes. Rab5-mediated en-
docytosis is responsible for N-cadherin internalization in neuronal cells
[16]. Additionally, silencing of Rab5 expression resulted with an in-
creased level of N-cadherin on the cell surface [27]. The endocytosis
mediated by Rab5 and Dynamin is a fundamental process in neuronal
migration, and the main loading molecule of Rab5 in the neuronal
migration is N- cadherin. Additionally, an increase in the amount of
Rab5 promotes basal autophagy [28]. Another protein involved in au-
tophagosome maturation is Rab7. Although we did not notice any
significant changes in the level of Rab7 after silencing of ILK in mela-
noma, we observed a meaningful increase in the expression of Rab9
Fig. 2. The effect of ILK silencing on cadherin expression. E-cadherin and N-cadherin expression on mRNA level was determined by reverse transcription-PCR 48 h
after transfection.”+” refers to siRNA ILK; “-“refers to control cells. The GAPDH mRNA level was used as an intrinsic control. Inhibition of ILK expression by siRNA is
sufficient to downregulate the expression of N-cadherin on protein level in both cell lines. β-actin was selected to probe membranes for the protein loading. Shown
are representative membranes of at least three separate experiments with similar results.
Fig. 3. ILK regulates expression and cellular localization of markers of EMT (N-cadherin and key transcriptional factors). “+” refers to siRNA ILK; “-“refers to control
cells. Subcellular compartment extracts – Cytoplasmic (C), nuclear (N), membrane (M) and cytoskeleton (S) – were prepared as described in Materials and Methods.
As controls to prove separation and purity of isolated fractions were used calnexin and vimentin. Shown are representative membranes of at least three separate
experiments with similar results.
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which is required in non-canonical autophagy [29].
The presence of N-cadherin at the plasma membrane surface is also
dependent on transition after its endocytic uptake via recycling from
the early endosome back to plasma membrane. This is supported by
Rab4 positive endosomes in the fast-range pathway or Rab 11 positive
recycling endosomes in the slow-range pathway. Ho and colleagues
proved that ILK can regulate endosomes recycling by modulation of
microtubule stability and interaction with Rab4 and Rab11 containing
endosomes [18]. Rab11 enhances the trafficking of internalized N-
cadherin to the plasma membrane via recycling endosomes which
promotes neuronal migration [27]. Our data indicated that ILK sig-
naling can regulate the expression of Rab4 and Rab11 proteins, well-
known regulators of recycling processes and exocytosis. Moreover,
Lindsay and McCaffrey showed that knockdown of Rab coupling
Fig. 4. ILK regulates Rab proteins expression. Protein expression was studied by Western blot 48 h after transfection.”+” refers to siRNA ILK; “-“refers to control
cells, as described in Materials and Methods. The histograms are a quantitative representation of data after densitometry (mean ± SD) of three independent
experiments. β-actin was used as a protein loading control. Asterisks indicate significant differences from control cells. Values are denoted as *p < .05, **p < .01,
and ***p < .001.
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protein (a Rab11 effector protein) inhibits the return of endocytosed N-
cadherin in lung adenocarcinoma cells [9]. We also noticed a decrease
of Rab11 interacting protein (Rab11FIP1) after silencing of ILK. In our
previous work, we observed a decrease in the expression of N-cadherin
after ILK silencing in melanoma cells [5]. Presented results show that in
melanoma, ILK pathway regulates expression of N-cadherin at the
protein level by controlling their presence in the membrane fraction.
This phenomenon has also physiological consequences, because we
observe reduced adhesion to endothelium and significantly reduced
transendothelial migration of melanoma cells after ILK silencing in
comparison to control cells. The results confirm previous reports, that
N-cadherin silencing reduces trnasendothelial melanoma cell migration
[30], and with our earlier observations that it significantly inhibits
melanoma cell migration through matrigel-coated Boyden chamber [4].
Rab11 also functions as an oncoprotein; high expression of Rab11 is
associated with multiple biological processes of cancer such as tumor
formation, progression, and poor prognosis [31,32]. Considering how
important a factor expression of Rab11 is in tumorigenesis, our result is
not without significance.
Our observation that ILK regulates expression of Rab proteins in-
dicates that ILK may function as an upstream regulator of endocytic
circuitries and be a critical player in fundamental intracellular traf-
ficking pathways, and thus participate in the EMT process.
ILK is a key regulator of several signaling pathways. Its kinase ac-
tivity results in phosphorylation of Ser 473 and activation of Akt, which
coordinates survival genes. ILK can also inactivate GSK-3 kinase by
direct phosphorylation at Ser 9, what leads to activation of some
transcription factors implicated in the regulation of EMT markers
[5,19]. Moreover, Akt/GSK-3β signaling cascade was indicated as a
regulator of Dynamin-1 dependent clathrin-mediated endocytosis [33].
On the other hand, many Rab proteins participate in the regulation of
Akt/ GSK-3β signaling pathways [31,34]. Rab proteins might function
as both oncogens and suppressors, so a strategy based on the regulation
of Rab expression would be reasonable in cancer treatment [13,34]. In
view of the fact that exocytosis pathway regulated by Rab proteins
plays an essential role in human cancer development, it may also be a a
good target in tumor therapy.
5. Conclusion
Our results suggest that ILK regulates N-cadherin expression at the
post-transcriptional level by controlling endosomal recycling (Fig. 8).
These data highlight an important mechanism of cadherin trafficking
regulation during tumor progression by integrin mediated signaling
pathway. This extends the area for development of novel therapeutic
strategies in cancer treatment, especially in targeted therapy.
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